Blog

The Future of Prevention: Moving Beyond Vaccines with e4life Technology

Recent public health events, such as the COVID-19 pandemic and the evolutionary trends of avian influenza, have shifted the focus toward new defense strategies. These are designed to mitigate infection risks related to indoor air, supplementing vaccination campaigns and traditional mitigation measures. In this context, e4life stands out by offering cutting-edge solutions like e4shield™ technology. In this article, we will describe the potential of this tool, highlighting its operating principles and associated benefits.

The Third Way of Prevention: Active Environmental Protection

Containing the infection risk linked to respiratory viruses relies on immunization through vaccines and behavioral measures, including the use of masks and social distancing. Alongside initiatives involving the individual, there are tools that intervene in the environment, such as filtration systems. The latter, in particular, acts as a passive measure, capable of cleaning the air without neutralizing pathogens. In this field, new protection devices have emerged today, capable of acting proactively against viruses present in indoor air. e4shield™ technology undoubtedly falls among these solutions, perfectly fitting this criterion. Specifically, the devices designed by e4life are not limited to passive air filtration; instead, they generate a protective cloud in the surrounding environment, damaging viral agents present in bioaerosols. Among other things, they ensure continuous, real-time sanitization, covering a space of 50 m² for environmental devices and up to a 3-meter radius for personal protection devices.

Why Mechanical Filtration (HEPA) Systems Alone Are No Longer Enough

Air purifiers equipped with HEPA filters (High-Efficiency Particulate Air) represent a standard for air quality action. They mechanically capture suspended particles, yet they remain inadequate for the comprehensive management of respiratory viruses. Below are the limitations of such equipment:

  • Non-Proactive Action: Air filtration is a passive mechanism that merely cleans the air drawn into the device. Furthermore, its effectiveness is linked to air circulation; unventilated spots, essentially, can easily remain contaminated.
  • Trapping Without Inactivation: HEPA filters capture viruses without inactivating them. At times, pathogens remain viable on the filter, which then becomes a contaminated surface.
  • Filtration Efficiency: HEPA filters can capture 99.97% of particles with a diameter of 0.3 microns (µm). Although they also act on smaller particles through diffusion, their efficiency is not guaranteed for smaller viruses.
  • System Leaks: Many filtration devices suffer from system leaks. In other words, contaminated air flows through gaps and crevices, bypassing the filter. Intuitively, this drawback slashes the total efficiency of the purifier.
  • Maintenance Costs and Environmental Impact: HEPA filters must be replaced periodically (according to guidelines), resulting in ongoing maintenance costs. Furthermore, removed filters are not recyclable and fall under waste disposal categories. In contrast, e4life devices do not use filters and require no maintenance, eliminating hidden costs and environmental impact.
  • Noise and Energy Consumption: The structural features of filtration devices are often associated with noise and motor wear. Additionally, a deteriorated system can lead to increased energy consumption on utility bills.

The Science Behind e4life: Inactivating Viruses Without Chemicals

The e4shield™ technology is an innovation born during the pandemic. Overall, it does not require chemicals to function but instead utilizes the SRET phenomenon (Structure Resonant Energy Transfer). The basic principle compares viral features to those of a battery. Specifically, negative charges are arranged on the outer shell of the pathogen, while positive charges are located in its innermost part. e4life devices produce an oscillating magnetic field that enters into resonance with the virus, emitting microwaves at a specific frequency. Ultimately, these oscillations cause the viral envelope to break, neutralizing any danger.

An important aspect concerns the selectivity of the tool. The resonance frequencies of viruses (in the GHz range) depend on structural and functional peculiarities that are very different from those of a cell. This ensures lethality for viruses while being harmless to people and animals. The power of the microwaves used is very low, significantly lower than that of a Wi-Fi device. The technology complies with international safety standards, meeting CE and SAR (Specific Absorption Rate) certifications.

Scientific Validations and Laboratory Test Results

To date, the efficiency of the devices in terms of viral inactivation stands above 90%. Safety and efficacy requirements have been validated through a rigorous scientific process. Below is a brief overview of the institutions involved and their roles:

  • Scientific Department of the Celio Military Polyclinic (Rome): Instrumental in defining the operational range for the inactivation of the SARS-CoV-2 virus. It also validated protocols and results from other research sites.
  • ViroStatics Independent Research Laboratories: Conducted specific tests to simulate the behavior of respiratory viruses dispersed in bioaerosols. The conclusion of these tests revealed the aforementioned efficiency threshold.
  • Department of Biomedical and Clinical Sciences at the University of Milan: Reproduced and confirmed observations on SARS-CoV-2 and seasonal influenza strains (H1N1), obtaining results consistent with previous tests.
  • Campus Bio-Medico of Rome and the University of Genoa: Contributed to the experimental design and efficacy verifications.

Research findings have been published in international scientific journals, such as Viruses (MDPI). The technology was examined in a study published by the European Society of Medicine (ESMED) and included in the report “Suppressing indoor pathogen transmission: A Technology Foresight study” by the Joint Research Centre (JRC) of the European Commission. It has also been included in the reference practices UNI/PdR 173-1:2025.

The efficacy of e4shield™ was first verified for SARS-CoV-2 and its variants, then extended to other viral types, such as influenza strains and the respiratory syncytial virus (RSV). Future research also anticipates application tests on bacterial pathogens.

Investing in Health: Benefits for Companies and the Public Sector

Solutions like e4shield™ represent not just an additional means of defense for public health, but also a advantageous investment for the workplace and society. Promoting the healthiness of common spaces creates economic, social, and environmental value. Let’s look at the benefits for companies:

  • Fewer Absences and Higher Productivity: Healthier workplaces discourage the transmission of seasonal infections like the flu and other respiratory diseases. This leads to a reduction in sick days and an increase in productivity.
  • Continuity and Resilience: The ability to act proactively on work environments enhances operational and productive continuity, especially during epidemic peaks and health emergencies.
  • Sustainability: e4life technology is a sustainable solution, as it requires no chemical components, produces no waste material for disposal, and does not significantly impact energy consumption. Essentially, it aligns with the United Nations Sustainable Development Goals (SDGs).
  • Attracting Talent: A company that demonstrates concern for employee health is more attractive to potential talent. Welcomed into a safe and well-cared-for environment, employees dedicate themselves to work with commitment, trust, and a sense of belonging.

Alongside the advantages for the working world, there are also favorable aspects for the community, listed below:

  • Protection of Public Spaces: This technology is suitable for the continuous sanitization of high-traffic areas such as schools, public transport, hospitals, offices, etc. Maintaining the healthiness of these environments is an essential, though not always guaranteed, measure for public well-being.
  • Support for the Healthcare System: The e4life solution contributes to the overall mitigation of infection risk, reducing pressure on the healthcare system and increasing service efficiency.
  • A Concrete “One Health” Approach: The technology’s proven effectiveness against various viral strains places e4shield™ among the strategic tools of the “One Health” approach. In practice, this consists of preventing viral transmission between animal species and humans, mitigating the risks associated with potential zoonoses.

Frequently Asked Questions (FAQ)

How does e4life differ from a common air purifier?

A classic air purifier equipped with HEPA filters is a passive measure: it draws in air and captures suspended particles, including viruses, on the surface of a filter. e4life devices, however, are an active measure. They do not just capture viruses but inactivate them directly and instantaneously.

Is resonance technology safe for people and animals?

Yes, the technology is completely safe. It is designed to specifically target the structural features of viruses, which differ significantly from those of human or animal cells. Furthermore, the power of the emitted waves is very low, less than that of a Wi-Fi router.

What are the energy costs of an active protection system?

Unlike many air purifiers, e4life devices boast high energy efficiency. The associated consumption is negligible, allowing for continuous activation throughout the day.

Do e4life devices replace the vaccine?

No. e4life devices are offered as a complementary measure. While vaccines immunize the individual, limiting the severity of potential infection symptoms, this technology acts on the viral presence in bioaerosols, reducing the probability of contagion.

Which viruses can e4life inactivate?

The efficacy of e4shield™ has proven successful, with an efficiency exceeding 90%, against various human and animal viruses. These include SARS-CoV-2, influenza viruses, and Respiratory Syncytial Virus (RSV). Studies on targets are extending to other pathogens, including bacterial ones.

Contact us